Welcome to LookChem.com Sign In|Join Free
  • or
5-hydroxy-2,3-dihydroindolizin-7(1H)-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

58156-35-7

Post Buying Request

58156-35-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

58156-35-7 Usage

Commonly known as

5-HDI

Class

Indolizidine alkaloid

Found in

Various plant species, including members of the Fabaceae family

Pharmacological properties

Anti-inflammatory, anti-cancer, anti-microbial

Potential uses

Therapeutic agent for various medical conditions
Promising compound for medicine and drug development

Check Digit Verification of cas no

The CAS Registry Mumber 58156-35-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,1,5 and 6 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 58156-35:
(7*5)+(6*8)+(5*1)+(4*5)+(3*6)+(2*3)+(1*5)=137
137 % 10 = 7
So 58156-35-7 is a valid CAS Registry Number.

58156-35-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1H-Indolizin-5-one, 2,3-dihydro-7-hydroxy

1.2 Other means of identification

Product number -
Other names 7-hydroxy-2,3-dihydro-1H-indolizin-5-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:58156-35-7 SDS

58156-35-7Relevant academic research and scientific papers

Propionic Acid Derivatives and Methods of Use Thereof

-

Paragraph 1811; 1814, (2018/11/21)

Provided herein are compounds and pharmaceutical compositions of formula I where R1, R2, R3, R4, R5 and R6 are as described herein. Also provided pharmaceutically acceptable salts or stereoisomers of these compounds. In addition methods are provided for inhibiting the binding of an integrin to treat various pathophysiological conditions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 58156-35-7